Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2757-2764

  Lenz, Christian ^a   Scheid, Andreas ^a   Schaal, Heiner ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Inst for Med Microbiol/Virology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; MESSENGER RNA; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; EXON; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NORTHERN BLOTTING; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS TRANSCRIPTION;

EID: 0030891506     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2757-2764.1997     Document Type: Article

References (50)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Adams, M., L. Sharmeen, J. Kimpton, J. M. Romeo, J. V. Garcia, B. M. Peterlin, M. Groudine, and M. Emerman. 1994. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA 91:3862-3866.
3. Agy, M. B., C. H. Sherbert, and M. G. Katze. 1996. Development of an in vitro mRNA degradation assay utilizing extracts from HIV-1-and SIV-infected cells. Virology 217:158-166.
4. Ashe, M. P., P. Griffin, W. James, and N. J. Proudfoot. 1995. Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev. 9:3008-3025.
5. Bender, T. P. 1990. Identification of newly transcribed RNA, p. 4.10.5-4.10.10. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York, N.Y.
6. Bird, P., M. J. Gething, and J. Sambrook. 1987. Translocation in yeast and mammalian cells: not all signal sequences are functionally equivalent. J. Cell Biol. 105:2905-2914.
7. Blair, E. D., C. C. Blair, and E. K. Wagner. 1987. Herpes simplex virus virion stimulatory protein mRNA leader contains sequence elements which increase both virus-induced transcription and mRNA stability. J. Virol. 61: 2499-2508.
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Cochrane, A. W., K. S. Jones, S. Beidas, P. J. Dillon, A. M. Skalka, and C. A. Rosen. 1991. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:5305-5313.
10. Cullen, B. R. 1986. trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46:973-982.
11. Cullen, B. R. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73:417-420.
12. Dayton, A. I., J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44:941-947.
13. Derse, D., and J. W. Casey. 1986. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression. Science 231:1437-1440.
14. el Kharroubi, A., and M. A. Martin. 1996. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:2958-2966.
15. el Kharroubi, A., and E. Verdin. 1994. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269:19916-19924.
16. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991 The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-1049.
17. Fisher, A. G., M. B. Feinberg, S. F. Josephs, M. E. Harper, L. M. Marselle, G. Reyes, M. A. Gonda, A. Aldovini, C. Debouk, R. C. Gallo, et al. 1986. The trans-activator gene of HTLV-III is essential for virus replication. Nature 320:367-371.
18. Hultmark, D., R. Klemenz, and W. J. Gehring. 1986. Translational and transcriptional control elements in the untranslated leader of the heat-shock gene hsp22. Cell 44:429-438.
19. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
20. Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-493.
21. Kashanchi, F., J. F. Duvall, P. F. Lindholm, M. F. Radonovich, and J. N. Brady. 1993. Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression. J. Virol. 67:2894-2902.
22. Kessler, M., and M. B. Mathews. 1992. Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts. J. Virol. 66:4488-4496.
23. Kim, S. Y., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63:3708-3713.
24. Klotman, M. E., S. Kim, A. Buchbinder, A. DeRossi, D. Baltimore, and F. Wong Staal. 1991. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 88:5011-5015. (Erratum, 89:1148, 1992.)
25. Kozak, M. 1987. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125-8148.
26. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
27. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1990. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev. 4:2397-2408.
28. Lu, X., T. M. Welsh, and B. M. Peterlin. 1993. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J. Virol. 67:1752-1760.
29. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
30. Maldarelli, F., M. A. Martin, and K. Strebel. 1991. Identification of post-transcriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:5732-5743.
31. Mansour, S. L., T. Grodzicker, and R. Tjian. 1986. Downstream sequences affect transcription initiation from the adenovirus major late promoter. Mol. Cell. Biol. 6:2684-2694.
32. Mikaelian, I., M. Krieg, M. J. Gait, and J. Karn. 1996. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs. J. Mol. Biol. 257:246-264.
33. Muesing, M. A., D. H. Smith, and D. J. Capon. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48:691-701.
34. Myers, G., B. Korber, B. H. Hahn, K. T. Jeang, J. W. Mellors, F. E. Me-Cutchan, L. E. Henderson, and G. N. Pavlakis. 1995. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.M.
35. Nasioulas, G., A. S. Zolotukhin, C. Tabernero, L. Solomin, C. P. Cunningham, G. N. Pavlakis, and B. K. Felber. 1994. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68:2986-2993.
36. Reddy, T. R., G. Kraus, M. Suhasini, M. C. Leavitt, and F. Wong Staal. 1995. Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene. J. Virol. 69:5167-5170.
37. Rosen, C. A., E. Terwilliger, A. Dayton, J. G. Sodroski, and W. A. Haseltine. 1988. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85:2071-2075.
38. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
39. Schaal, H., M. Klein, P. Gehrmann, O. Adams, and A. Scheid. 1995. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J. Virol. 69:3308-3314.
40. Schaal, H., P. Pfeiffer, M. Klein, P. Gehrmann, and A. Scheid. 1993. Use of DNA end joining activity of a Xenopus laevis egg extract for construction of deletions and expression vectors for HIV-1 Tat and Rev proteins. Gene 124:275-280.
41. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
42. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:150-159.
43. Selby, M. J., E. S. Bain, P. A. Luciw, and B. M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558.
44. Selden, R. F., K. B. Howie, M. E. Rowe, H. M. Goodman, and D. D. Moore. 1986. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6:3173-3179.
45. Shiau, A., and J. M. Smith. 1988. Improved cat gene cassette for promoter analysis and genetic constructions. Gene 67:295-299.
46. Sodroski, J., R. Patarca, C. Rosen, F. Wong Staal, and W. Haseltine. 1985. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science 229:74-77.
47. Sodroski, J., C. Rosen, F. Wong Staal, S. Z. Salahuddin, M. Popovic, S. Arya, R. C. Gallo, and W. A. Haseltine. 1985. trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 227:171-173.
48. Strebel, K., D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M. A. Martin. 1987. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328:728-730.
49. Theill, L. E., O. Wiborg, and J. Vuust. 1987. Cell-specific expression of the human gastrin gene: evidence for a control element located downstream of the TATA box. Mol. Cell. Biol. 7:4329-4336.
50. Toohey, M. G., and K. A. Jones. 1989. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes Dev. 3:265-282.